Kisunla 17.5 mg/mL

Active Ingredient:
donanemab-azbt
Form:
INJECTION, SOLUTION
Brand:
Kisunla
Origin:
USA

Buy Kisunla 17.5 mg/mL donanemab-azbt

Kisunla 17.5 mg/mL is an intravenous solution used for the treatment of Alzheimer's disease. This single-dose injection, manufactured by Eli Lilly and Company, contains donanemab-azbt and is designed for specific therapeutic applications.

Strength

17.5 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Manufacturer

Eli Lilly and Company

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Kisunla 17.5 mg/mL is primarily used in the management of Alzheimer's disease. This medication is part of a treatment regimen aimed at addressing the underlying mechanisms of the condition. Patients and healthcare providers often explore what Kisunla is used for in the context of neurodegenerative therapies.

Side Effects

  • Kisunla 17.5 mg/mL may cause common effects such as infusion-related reactions, which can include symptoms like headache, nausea, and fatigue. These effects are typically monitored and managed by healthcare professionals during and after administration.

Precautions & Warnings

  • Kisunla 17.5 mg/mL should be handled with care, following the guidelines provided by healthcare professionals. It is important to store and administer this medication as directed to ensure safety and efficacy. Patients should discuss any pre-existing conditions or allergies with their healthcare provider before use.

Avoid Interactions

  • Kisunla 17.5 mg/mL may interact with other medications, particularly those that affect the immune system or are metabolized by similar pathways. It is advisable to inform healthcare providers about all current medications to avoid potential interactions.

References

Frequently Asked Questions

Kisunla 17.5 mg/mL is used in the treatment of Alzheimer's disease, targeting specific mechanisms associated with the condition.

Kisunla 17.5 mg/mL is administered intravenously as a single-dose solution.

Common effects may include infusion-related reactions such as headache, nausea, and fatigue.

Kisunla 17.5 mg/mL is manufactured by Eli Lilly and Company.

Patients should follow the storage and administration guidelines provided by healthcare professionals and discuss any pre-existing conditions or allergies with their provider.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use.

If you wish to request the removal of a product or any part of its content, please contact us at legal@gnhindia.com.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT